Bisson, from Queen's University in Kingston, Ontario, Canada, and colleagues evaluated FRAX
performance for people with MS when bone mineral density (BMD) was known.
The discriminative ability of FRAX
, the WHO algorithm, to identify women with prevalent asymptomatic vertebral fractures: a cross-sectional study.
is a computerbased tool that is used to tell you how likely you are to have a bone fracture.
One-way ANOVA analysis of variance detected statistically significant differences between groups (p < 0.05) in hemoglobin, erythrocyte, iron, triglyceride, cholesterol, erythrocyte sedimentation rate, and FRAX
The purpose of this study was to explore the relationship of the 10-year probability of a hip fracture (HF) and a major osteoporotic fracture (MOF) as calculated with the FRAX
and CAC scores.
In the Introduction, FRAX
is described as "the World Health Organization's fracture risk assessment tool".
uses height, weight and medical, smoking and family history to predict a person's risk of developing osteoporosis over the next 10 years.
tool risk assessment, Centre for Metabolic Bone Diseases, University of Sheffield, UK.
Considering the high prevalence of HO, every patient with CLD should have complete evaluation of bone mass by detecting vitamin D and blood calcium levels, measuring BMD by DXA, besides using FRAX
. The thyroid and gonadal functions should also be evaluated in patients to exclude other forms of osteoporosis (Table 4).
If the FRAX
indicates that you have at least a 20 percent risk of a major fracture or at least a 3 percent risk of a hip fracture over 10 years, it's a good idea to get treatment.
declared that trabecular bone score (TBS) and fracture riskassessment tool (FRAX
) adjustedwith TBS (T-FRAX) showed an amplified predictive ability in the evaluation of risk of fragility fractures in patients receiving glucocorticoid therapy.
The article notes: "The WHO has developed an absolute fracture risk assessment tool ('FRAX
') to estimate the 10-year fracture risk in all adults, which is based on the integration of femoral neck bone density, age and other important clinical risk factors ." However, the World Health Organization (WHO) did not develop, test, or endorse the FRAX
tool or its recommendations .